Candriam Equities L Oncology Impact PI/ LU1864483836 /
| NAV05/06/2024 | Chg.+28.4700 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 2,558.2000USD | +1.13% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | - | 2.70 | -3.61 | -2.53 | 8.73 | 0.34 | -0.24 | -3.14 | 5.14 | 8.00 | 5.07 | - |
| 2020 | -1.43 | -5.31 | -3.03 | 12.16 | 8.58 | 1.46 | 4.47 | 2.19 | 3.55 | -2.17 | 5.86 | 3.90 | +33.03% |
| 2021 | 0.58 | -4.17 | -0.05 | 2.37 | 0.21 | 3.57 | -0.93 | 5.62 | -3.73 | 3.41 | -6.33 | 4.03 | +3.90% |
| 2022 | -10.46 | -1.72 | 4.69 | -5.82 | -1.29 | 0.08 | 4.40 | -3.10 | -4.68 | 7.08 | 6.11 | -3.41 | -9.27% |
| 2023 | 2.20 | -3.85 | 1.42 | 2.86 | -2.52 | 0.12 | 0.93 | -1.98 | -5.21 | -6.32 | 9.26 | 5.77 | +1.56% |
| 2024 | 1.41 | 4.18 | 1.53 | -3.34 | 2.52 | 2.16 | - | - | - | - | - | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 10.74% | 10.99% | 11.68% | 14.67% | 17.20% |
| Ratio de Sharpe | 1.64 | 2.43 | 0.35 | -0.15 | 0.43 |
| Le meilleur mois | +5.77% | +5.77% | +9.26% | +9.26% | +12.16% |
| Le plus défavorable mois | -3.34% | -3.34% | -6.32% | -10.46% | -10.46% |
| Perte maximale | -6.73% | -6.73% | -15.24% | -24.42% | -24.42% |
| Surperformance | +16.58% | - | +23.21% | - | - |
Toutes les cotations dans USD
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,393.9099 | +7.72% | +4.62% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,558.2000 | +7.86% | +5.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.0400 | +4.18% | -6.19% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,229.6499 | +4.43% | +15.08% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,606.3300 | +7.38% | +3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 244.6500 | +4.85% | +12.98% | |
| Candriam Equities L Oncology Imp... | paying dividend | 235.4400 | +6.37% | +0.75% | |
| Candriam Equities L Oncology Imp... | paying dividend | 190.7200 | +7.27% | +3.31% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,641.0000 | +2.52% | +0.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.7300 | +4.31% | +14.69% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,106.0200 | +5.17% | -3.50% | |
| Candriam Equities L Oncology Imp... | reinvestment | 259.3200 | +5.74% | +15.86% | |
| Candriam Equities L Oncology Imp... | reinvestment | 206.4900 | +3.76% | -7.29% | |
| Candriam Equities L Oncology Imp... | reinvestment | 285.9900 | +7.27% | +3.30% | |
| Candriam Equities L Oncology Imp... | reinvestment | 193.4200 | +5.05% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,839.3500 | +4.77% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,843.2800 | +6.18% | +3.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.2500 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 270.5100 | +5.19% | +0.71% |
Performance
| CAD | +8.57% | ||
|---|---|---|---|
| 6 Mois | +14.18% | ||
| 1 An | +7.86% | ||
| 3 Ans | +5.01% | ||
| 5 Ans | +69.26% | ||
| 10 ans | - | ||
| Depuis le début | +69.79% | ||
| Année | |||
| 2023 | +1.56% | ||
| 2022 | -9.27% | ||
| 2021 | +3.90% | ||
| 2020 | +33.03% | ||
